ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 3593

$1.3M Total Retail Price of All Prescriptions

Rank: 73 out of 3593

550 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 21,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 979 885 1 3
OMEPRAZOLE 961 894 2 5
SIMVASTATIN 631 554 3 1
METOPROLOL TARTRATE 621 607 4 8
LEVOTHYROXINE SODIUM 606 568 5 4
LISINOPRIL 576 552 6 2
GABAPENTIN 475 396 7 16
CRESTOR 457 420 8 21
METFORMIN HCL 383 345 9 6
ZOLPIDEM TARTRATE 349 303 10 12
ALPRAZOLAM 342 326 11 37
FAMOTIDINE 340 332 12 70
NAMENDA 339 319 13 50
TRAZODONE HCL 319 287 14 53
LOSARTAN POTASSIUM 313 274 15 14
HYDROCHLOROTHIAZIDE 306 283 16 10
DONEPEZIL HCL 301 285 17 31
FUROSEMIDE 296 263 18 9
CLOPIDOGREL 280 261 19 30
CARVEDILOL 241 211 20 23
NEXIUM 233 180 21 36
ALENDRONATE SODIUM 233 210 21 22
PLAVIX 231 214 23 42
BENICAR 222 200 24 131
ATORVASTATIN CALCIUM 215 184 25 15
TEMAZEPAM 200 181 26 56
CITALOPRAM HBR 192 173 27 25
DIOVAN 187 165 28 46
CLOTRIMAZOLE-BETAMETHASONE 182 159 29 94
PAROXETINE HCL 165 141 30 62
CIPROFLOXACIN HCL 164 153 31 52
GLYBURIDE 164 153 R 31 55
GLIPIZIDE 151 139 33 40
NORTRIPTYLINE HCL 150 150 34 296
AZITHROMYCIN 149 146 35 34
CLONIDINE HCL 145 129 36 41
WARFARIN SODIUM 143 143 37 18
QUETIAPINE FUMARATE 143 136 37 89
ALBUTEROL SULFATE 139 134 39 157
RANITIDINE HCL 139 123 39 27
ATENOLOL 136 136 41 11
LANSOPRAZOLE 134 118 42 113
ADVAIR DISKUS 130 99 43 47
FENOFIBRATE 128 120 44 39
TAMSULOSIN HCL 127 121 45 33
PREDNISONE 125 119 46 49
DIGOXIN 124 124 47 58
MUPIROCIN 124 117 47 132
IBUPROFEN 122 97 49 43
AMOX TR-POTASSIUM CLAVULANATE 122 113 49 138
DOXAZOSIN MESYLATE 120 108 51 63
MECLIZINE HCL 119 115 52 96
SINGULAIR 118 95 53 77
RISPERIDONE 116 116 54 83
NIFEDIPINE ER 115 82 55 75
MEGESTROL ACETATE 114 112 R 56 152
LYRICA 113 107 57 105
METOPROLOL SUCCINATE 109 101 58 19
CARBIDOPA-LEVODOPA 106 106 59 135
TRAMADOL HCL 106 85 59 17
EXELON 105 105 61 123
PANTOPRAZOLE SODIUM 105 98 61 45
CELEBREX 105 85 61 100
LEVETIRACETAM 102 95 64 127
SERTRALINE HCL 100 83 65 28
LACTULOSE 99 78 66 126
LANTUS 97 97 67 57
LIDODERM 95 69 68 78
DICYCLOMINE HCL 93 79 69 190
SANTYL 93 91 69 208
NOVOLIN R 92 91 71 140
NOVOLOG MIX 70-30 91 82 72 283
NAPROXEN 90 83 73 68
KETOCONAZOLE 88 84 74 118
ENALAPRIL MALEATE 85 64 75 38
ESCITALOPRAM OXALATE 85 70 75 71
LOSARTAN-HYDROCHLOROTHIAZIDE 84 72 77 48
FLUTICASONE PROPIONATE 81 79 78 32
IPRATROPIUM BROMIDE 81 79 78 210
NOVOLOG 81 81 78 134
TRAMADOL HCL-ACETAMINOPHEN 78 71 81 147
TIMOLOL MALEATE 78 70 81 295
GENERLAC 77 64 83 271
SILVER SULFADIAZINE 74 71 84 248
AMLODIPINE BESYLATE-BENAZEPRIL 74 74 84 65
ACTONEL 74 62 84 197
SEROQUEL 72 69 87 172
BENICAR HCT 71 71 88 155
POTASSIUM CHLORIDE 68 60 89 24
OXYCODONE-ACETAMINOPHEN 68 61 S2 89 93
CYCLOBENZAPRINE HCL 65 48 R 91 72
ENOXAPARIN SODIUM 64 55 92 291
HUMULIN R 64 64 92 353
DIOVAN HCT 60 60 94 76
CILOSTAZOL 60 59 94 163
WELCHOL 59 52 96 285
ACETAMINOPHEN-CODEINE 59 56 S3 96 153
DILTIAZEM 24HR CD 59 59 96 173
CIALIS 58 51 99 176
VOLTAREN 57 54 100 85
PENTOXIFYLLINE 56 56 101 149
IPRATROPIUM-ALBUTEROL 56 56 101 154
DICLOFENAC SODIUM 55 55 103 74
INSULIN SYRINGE 55 47 103 91
METOCLOPRAMIDE HCL 54 49 105 145
LOVASTATIN 53 53 106 20
VANCOMYCIN HCL 52 52 107 407
MONTELUKAST SODIUM 52 50 107 151
PHENYTOIN 52 52 107 326
NIFEDICAL XL 51 50 110 281
NOVOLIN 70-30 51 50 110 146
MEROPENEM 50 48 112 511
ENULOSE 50 50 112 341
AGGRENOX 50 50 112 288
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.